Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries

Globally, group B Streptococcus (GBS) remains the leading cause of sepsis and meningitis in young infants, with its greatest burden in the first 90 days of life. Intrapartum antibiotic prophylaxis (IAP) for women at risk of transmitting GBS to their newborns has been effective in reducing, but not e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Miwako, Vekemans, Johan, Baker, Carol J., Ratner, Adam J., Le Doare, Kirsty, Schrag, Stephanie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070600/
https://www.ncbi.nlm.nih.gov/pubmed/27803803
http://dx.doi.org/10.12688/f1000research.9363.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070600/
https://www.ncbi.nlm.nih.gov/pubmed/27803803
http://dx.doi.org/10.12688/f1000research.9363.1

Ejemplares similares